Immune to Cancer: The CRI Blog
-
AACR19 Day 5 Update: Bispecific Antibodies, the Importance of “Helper” T Cells, and the Lloyd J. Old Award Lecture
Scientists tackled novel immunotherapy strategies that could potentially enable more patients with more types of cancer to…
-
AACR19 Day 4 Update: The Microbiome, Immunotherapy Biomarkers, and New Immune Targets
Day 4 of AACR19 explored the microbiome and its impact on cancer treatment, revealed insights into immunotherapy…
-
AACR19 Day 3 Update: CAR T Cells, Vaccines, and Hope Against Pancreatic Cancer
In addition to advances involving CAR T cell therapy and vaccines, a CRI-funded trial revealed the promise…
-
CRI-Funded Trial Reveals Promising Potential of Immunotherapy Combination in Metastatic Pancreatic Cancer
Interim data from a novel immunotherapy-chemotherapy combination that targets the CD40 and PD-1 pathways show promising anti-tumor…
-
Personalizing Cancer Treatment
Dr. Patrick Hwu discusses the current state of cancer care and how recent advances are enabling doctors…
-
Transforming Experience into Advocacy
Judy Perkins discusses her experience receiving immunotherapy for metastatic stage 4 breast cancer and insights she shared…
-
AACR19 Preview: CRI Scientists Showcase the Future of Immunotherapy
The 2019 AACR annual meeting kicks off March 29 in Atlanta and will feature the work of…
-
Immunotherapy Combination Approved as First-Line Option for Patients with Advanced Triple-Negative Breast Cancer
Patients with advanced triple-negative breast cancer can now receive frontline treatment with immunotherapy in combination with chemotherapy.
-
Spin to Give to Cancer Research Institute
Laura Geminiana organized a unique birthday fundraiser this year: a spin class where she and members donated…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.